You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-1256-ESGO First experiences of implementing ‘enhanced recovery after surgery’ (ERAS) at two German ESGO centers of excellence – KORE-INNOVATION: the first prospective clinical trial to assess a perioperative pathway to reduce postoperative compli…

Citation Tools

Article menu

Download PDFPDF

Ovarian cancer
2022-RA-1256-ESGO First experiences of implementing ‘enhanced recovery after surgery’ (ERAS) at two German ESGO centers of excellence – KORE-INNOVATION: the first prospective clinical trial to assess a perioperative pathway to reduce postoperative complications in ovarian cancer patients
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Inci-Turan MG, Schneider S, Schnura E, et al
2022-RA-1256-ESGO First experiences of implementing ‘enhanced recovery after surgery’ (ERAS) at two German ESGO centers of excellence – KORE-INNOVATION: the first prospective clinical trial to assess a perioperative pathway to reduce postoperative complications in ovarian cancer patients
International Journal of Gynecologic Cancer 2022;32:A314.